Vericel (VCEL) - P/S ratio

P/S ratio as of December 2024 (TTM): 12.3

According to Vericel 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 10.9. At the end of 2024 the company had a P/S ratio of 9.34.

P/S ratio history for Vericel from 2001 to 2024

PS ratio at the end of each year

Year	P/S ratio	Change
2024	9.34	8.49%
2023	8.60	13.7%
2022	7.57	-35.76%
2021	11.8	4.28%
2020	11.3	70.55%
2019	6.62	-20.63%
2018	8.35	180.42%
2017	2.98	64.26%
2016	1.81	51.05%
2015	1.20	-52.23%
2014	2.51	-99.69%
2013	803	-69.44%
2012	> 1000	-32.75%
2011	> 1000	42.73%
2010	> 1000	1005.08%
2009	248	49.01%
2008	166	42.98%
2007	116	-34.69%
2006	178	-47.36%
2005	338	206.43%
2004	110	31.73%
2003	83.8	149.92%
2002	33.5	-46.05%
2001	62.1

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Royalty Pharma RPRX	6.53	-47.05%	🇬🇧 UK
Neogen NEOG	2.88	-76.64%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Vericel (VCEL)

P/S ratio as of December 2024 (TTM): 12.3